EXECUTIVE RETENTION AND SEPARATION AGREEMENTExecutive Retention and Separation Agreement • December 1st, 2015 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Maryland
Contract Type FiledDecember 1st, 2015 Company Industry JurisdictionThis Executive Retention and Separation Agreement (the "Agreement") is entered into as of November 24, 2015 by and between Emergent BioSolutions Inc., (the "Company"), and Barry Labinger (the "Executive" and together with the Company, the "Parties").
EXECUTIVE RETENTION AND SEPARATION AGREEMENTExecutive Retention and Separation Agreement • May 7th, 2020 • Moderna, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 7th, 2020 Company Industry JurisdictionThis Executive Retention Agreement (this “Agreement”) is entered into effective as of May 5, 2020 (the “Effective Date”) between Lorence Kim, M.D. (the “Executive”) and Moderna, Inc. (the “Company,” together with Executive, the “Parties”).